The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Osteosarcoma treatment – Where do we stand? A state of the art review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393
The Epidemiology of Osteosarcoma
Ottaviani, G., & Jaffe, N. (2009) · Cancer Treatment and Research · doi:10.1007/978-1-4419-0284-9_1 · Cited by 1,786
Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934
Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.14.0095 · Cited by 752
Self-citationChemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers, P. A., Heller, G., Healey, J., Huvos, A., Lane, J., Marcove, R., Applewhite, A., Vlamis, V, & Rosen, G. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.5 · Cited by 678
Self-citationKempf-Bielack, B., Bielack, S. S., Jürgens, H., Branscheid, D., Berdel, W. E., Exner, G. U., Göbel, U., Helmke, K., Jundt, G., Kabisch, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.063 · Cited by 643
Primary bone osteosarcoma in the pediatric age: State of the art
Longhi, A., Errani, C., De Paolis, M., Mercuri, M., & Bacci, G. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.05.005 · Cited by 631
Bacci, G., Longhi, A., Versari, M., Mercuri, M., Briccoli, A., & Picci, P. (2006) · Cancer · doi:10.1002/cncr.21724 · Cited by 569
Osteosarcoma: a review of diagnosis, management, and treatment strategies.
Geller, D. S., & Gorlick, R. G. (2010) · PubMed · Cited by 475
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
Anninga, J. K., Gelderblom, H., Fiocco, M., Kroep, J. R., Taminiau, A. H. M., Hogendoorn, P. C. W., & Egeler, R. M. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.05.030 · Cited by 456
Bacci, G., Ferrari, S., Bertoni, F., Ruggieri, P., Picci, P., Longhi, A., Casadei, R., Fabbri, N., Forni, C., Versari, M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.24.4016 · Cited by 438
Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegard, T. A., Picci, P., Capanna, R., Bernini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5785 · Cited by 435
Goorin, A. M., Schwartzentruber, D. J., Devidas, M., Gebhardt, M. C., Ayala, A. G., Harris, M. B., Helman, L. J., Grier, H. E., & Link, M. P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.165 · Cited by 395
Souhami, R. L., Craft, A. W., Van der Eijken, J. W., Nooij, M., Spooner, D., Bramwell, V. H., Wierzbicki, R., Malcolm, A. J., Kirkpatrick, A., Uscinska, B. M., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02307-6 · Cited by 383
Chemotherapy resistance in osteosarcoma: current challenges and future directions
Chou, A. J., & Gorlick, R. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.7.1075 · Cited by 377
Grignani, G., Palmerini, E., Dileo, P., Asaftei, S. D., D’Ambrosio, L., Pignochino, Y., Mercuri, M., Picci, P., Fagioli, F., Casali, P. G., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr151 · Cited by 359
Lewis, I. J., Nooij, M. A., Whelan, J., Sydes, M. R., Grimer, R., Hogendoorn, P. C. W., Memon, M. A., Weeden, S., Uscinska, B. M., van Glabbeke, M., et al. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk015 · Cited by 346
Self-citationFuchs, N., Bielack, S. S., Epler, D., Bieling, P., Delling, G., Körholz, D., Graf, N., Heise, U., Jürgens, H., Kotz, R., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008391103132 · Cited by 343
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
Ozaki, T., Flege, S., Kevric, M., Lindner, N., Maas, R., Delling, G., Schwarz, R., von Hochstetter, A. R., Salzer-Kuntschik, M., Berdel, W. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.142 · Cited by 342
Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Picci, P., Tienghi, A., Del Prever, A. B., Fagioli, F., Comandone, A., & Bacci, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.141 · Cited by 316
Osteosarcoma treatment: state of the art
Ta, H. T., Dass, C. R., Choong, P. F. M., & Dunstan, D. E. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9186-7 · Cited by 314
Bramwell, V. H., Burgers, M., Sneath, R., Souhami, R., van Oosterom, A. T., Voûte, P. A., Rouesse, J., Spooner, D., Craft, A. W., & Somers, R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.10.1579 · Cited by 313
Radiotherapy for local control of osteosarcoma
DeLaney, T. F., Park, L., Goldberg, S. I., Hug, E. B., Liebsch, N. J., Munzenrider, J. E., & Suit, H. D. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.051 · Cited by 306
Meyers, P. A., Gorlick, R., Heller, G., Casper, E., Lane, J., Huvos, A. G., & Healey, J. H. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2452 · Cited by 294
Self-citationOsteosarcoma of the spine: Experience of the Cooperative Osteosarcoma Study Group
Ozaki, T., Flege, S., Liljenqvist, U., Hillmann, A., Delling, G., Salzer‐Kuntschik, M., Jürgens, H., Kotz, R., Winkelmann, W., & Bielack, S. S. (2002) · Cancer · doi:10.1002/cncr.10258 · Cited by 283
Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Bielack, S., Carrle, D., & Casali, P. G. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp154 · Cited by 276
HMGB1 Promotes Drug Resistance in Osteosarcoma
Huang, J., Ni, J., Liu, K., Yu, Y., Xie, M., Kang, R., Vernon, P., Cao, L., & Tang, D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2001 · Cited by 275
Therapy for Osteosarcoma: Where Do We Go From Here?
Chou, A. J., Geller, D. S., & Gorlick, R. (2008) · Pediatric Drugs · doi:10.2165/00148581-200810050-00005 · Cited by 274
Link, M., Goorin, A. M., Horowitz, M. M., et al. (1991) · PubMed · Cited by 259
Osteosarcoma: Review of the Past, Impact on the Future. The American Experience
Jaffe, N. (2009) · Cancer Treatment and Research · doi:10.1007/978-1-4419-0284-9_12 · Cited by 252
A review of clinical and molecular prognostic factors in osteosarcoma
Clark, J. C. M., Dass, C. R., & Choong, P. F. M. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0330-x · Cited by 250
Bielack, S. S., Kempf-Bielack, B., Branscheid, D., Carrle, D., Friedel, G., Helmke, K., Kevric, M., Jundt, G., Kühne, T., Maas, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.2305 · Cited by 238
Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects
Janeway, K. A., & Grier, H. E. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70062-0 · Cited by 234
Saeter, G., Alvegård, T. A., Elomaa, I., Stenwig, A. E., Holmström, T., & Solheim, O. P. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.10.1766 · Cited by 225
Current strategies of chemotherapy in osteosarcoma
Carrle, D., & Bielack, S. S. (2006) · International Orthopaedics · doi:10.1007/s00264-006-0192-x · Cited by 217
Surgical outcomes in osteosarcoma
Grimer, R. J., Taminiau, A. M., & Cannon, S. R. (2002) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.84b3.0840395 · Cited by 216
Osteosarcoma: The COSS Experience
Bielack, S., Jürgens, H., Jundt, G., Kevric, M., Kühne, T., Reichardt, P., Zoubek, A., Werner, M., Winkelmann, W., & Kotz, R. (2009) · Cancer Treatment and Research · doi:10.1007/978-1-4419-0284-9_15 · Cited by 209
Whelan, J. S., Jinks, R. C., McTiernan, A., Sydes, M. R., Hook, J. M., Trani, L., Uscinska, B., Bramwell, V., Lewis, I. J., Nooij, M. A., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr491 · Cited by 205
Self-citationBacci, G., Rocca, M., Salone, M., Balladelli, A., Ferrari, S., Palmerini, E., Forni, C., & Briccoli, A. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21140 · Cited by 203
Prognostic factors and outcomes for osteosarcoma: An international collaboration
Pakos, E. E., Nearchou, A. D., Grimer, R. J., Koumoullis, H. D., Abudu, A., Bramer, J. A. M., Jeys, L. M., Franchi, A., Scoccianti, G., Campanacci, D., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.03.005 · Cited by 193
Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma
Ciernik, I. F., Niemierko, A., Harmon, D. C., Kobayashi, W., Chen, Y., Yock, T. I., Ebb, D. H., Choy, E., Raskin, K. A., Liebsch, N., et al. (2011) · Cancer · doi:10.1002/cncr.26037 · Cited by 191
Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival
Sæter, G., Høie, J., Stenwig, A. E., Johansson, A., Hannisdal, E., & Solheim, Ø. P. (1995) · Cancer · doi:10.1002/1097-0142(19950301)75:5<1084::aid-cncr2820750506>3.0.co;2-f · Cited by 190
Osteosarcoma over the age of forty
Grimer, R. J., Cannon, S. R., Taminiau, A. M., Bielack, S., Kempf-Bielack, B., Windhager, R., Dominkus, M., Saeter, G., Bauer, H., Meller, I., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00478-1 · Cited by 188
Bacci, G., Briccoli, A., Rocca, M., Ferrari, S., Donati, D., Longhi, A., Bertoni, F., Bacchini, P., Giacomini, S., Forni, C., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg286 · Cited by 187
Janeway, K. A., Barkauskas, D. A., Krailo, M. D., Meyers, P. A., Schwartz, C. L., Ebb, D. H., Seibel, N. L., Grier, H. E., Gorlick, R., & Marina, N. (2012) · Cancer · doi:10.1002/cncr.27414 · Cited by 179
Self-citationNeoadjuvant chemotherapy for osteosarcoma of the extremity
Bacci, G., Briccoli, A., Ferrari, S., Longhi, A., Mercuri, M., Capanna, R., Donati, D., Lari, S., Forni, C., & DePaolis, M. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00229-5 · Cited by 174
LINK, M. P., GOORIN, A. M., HOROWITZ, M., MEYER, W. H., BELASCO, J., BAKER, A., AYALA, A., & SHUSTER, J. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00003 · Cited by 171
The Role of Radiotherapy in Oseosarcoma
Schwarz, R., Bruland, Ø. S., Cassoni, A. M., Schomberg, P. J., & Bielack, S. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_7 · Cited by 167
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII
Smeland, S., Müller, C., Alvegard, T. A., Wiklund, T., Wiebe, T., Björk, O., Stenwig, A. E., Willén, H., Holmström, T., Follerås, G., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00747-5 · Cited by 166
Le Deley, M.-C., Guinebretière, J.-M., Gentet, J.-C., Pacquement, H., Pichon, F., Marec-Bérard, P., Entz-Werlé, N., Schmitt, C., Brugières, L., Vanel, D., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.10.023 · Cited by 162
Andreou, D., Bielack, S. S., Carrle, D., Kevric, M., Kotz, R., Winkelmann, W., Jundt, G., Werner, M., Fehlberg, S., Kager, L., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq589 · Cited by 158
Bacci, G., Longhi, A., Forni, C., Setola, E., & Ferrari, E. S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00546-x · Cited by 155
Neoadjuvant Chemotherapy and Local Radiotherapy for High-Grade Osteosarcoma of the Extremities
Machak, G. N., Si, T., Solovyev, Y. N., Sinyukov, P. A., Ivanov, S. M., Кочергина, Н. В., Ryjkov, A. D., Тепляков, В. В., Bokhyan, B. Y., & Glebovskaya, V. V. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.2.147 · Cited by 149
Winkler, K., Bielack, S., Delling, G., Salzer-Kuntschik, M., Kotz, R. I., Greenshaw, C., Jürgens, H., Ritter, J., Kusnierz-Glaz, C. R., Erttmann, R., et al. (1990) · Cancer · Cited by 146
Skip Metastases in Osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group
Kager, L., Zoubek, A., Kastner, U., Kempf‐Bielack, B., Potratz, J. C., Kotz, R. I., Exner, G. U., Franzius, C., Lang, S., Maas, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2978 · Cited by 139
Gelderblom, H. A. J., Jinks, R. C., Sydes, M. R., Bramwell, V. H. C., Glabbeke, M. M. V., Grimer, R. J., Hogendoorn, P. C. W., McTiernan, A., Lewis, I. J., Nooij, M. A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.036 · Cited by 136
Self-citationParkes, H. B., & 岩元, 巌. (1971) · Kenkyusha eBooks · Cited by 134
Orthopedic Surgery Options for the Treatment of Primary Osteosarcoma
Marulanda, G. A., Henderson, E. R., Johnson, D. A., Letson, G. D., & Cheong, D. (2008) · Cancer Control · doi:10.1177/107327480801500103 · Cited by 125
Osteosarcoma Multidisciplinary Approach to the Management from the Pathologist’s Perspective
Raymond, A. K., & Jaffe, N. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_4 · Cited by 125
Survival in high-grade osteosarcoma: improvement over 21 years at a single institution
Picci, P., Mercuri, M., Ferrari, S. M., Alberghini, M., Briccoli, A., Ferrari, C., Pignotti, E., & Bacci, G. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp502 · Cited by 109
Current Concepts on the Molecular Biology of Osteosarcoma
Gorlick, R. G. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_27 · Cited by 108
Nagarajan, R., Kamruzzaman, A., Ness, K. K., Marchese, V. G., Sklar, C. A., Mertens, A. C., Yasui, Y., Robison, L. L., & Marina, N. M. (2010) · Cancer · doi:10.1002/cncr.25446 · Cited by 105
Osteosarcoma: improvement in survival limited to high-grade patients only
Jawad, M. U., Cheung, M. C., Clarke, J., Koniaris, L. G., & Scully, S. P. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0923-7 · Cited by 103
International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience
Marina, N. M., Bielack, S., Whelan, J. S., Smeland, S., Krailo, M., Sydes, M. R., Butterfaß‐Bahloul, T., Calaminus, G., & Bernstein, M. L. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_18 · Cited by 102
Frontline treatment of localized osteosarcoma without methotrexate
Daw, N. C., Neel, M. D., Rao, B. N., Billups, C. A., Wu, J., Jenkins, J. J., Quintana, J. A., Luchtman‐Jones, L., Milena Villarroel, C., & Santana, V. M. (2011) · Cancer · doi:10.1002/cncr.25715 · Cited by 99
Emerging drugs for high-grade osteosarcoma
Hattinger, C. M., Pasello, M., Ferrari, S., Picci, P., & Serra, M. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2010.505603 · Cited by 99
The Incidence and Prognosis of Osteosarcoma Skip Metastases
Sajadi, K. R., Heck, R. K., Neel, M. D., Rao, B. N., Daw, N. C., Galindo, C. R., Hoffer, F. A., Stacy, G. S., Peabody, T. D., & Simon, M. A. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000141493.52166.69 · Cited by 97
Hauben, E. I., Arends, J., Vandenbroucke, J. P., van Asperen, C. J., Marck, E. V., & Hogendoorn, P. C. W. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201012 · Cited by 94
Second malignant neoplasms in long‐term survivors of osteosarcoma
Aung, L., Gorlick, R. G., Shi, W., Thaler, H. T., Shorter, N. A., Healey, J. H., Huvos, A. G., & Meyers, P. A. (2002) · Cancer · doi:10.1002/cncr.10861 · Cited by 90
Self-citationUpdate on Targets and Novel Treatment Options for High-Grade Osteosarcoma and Chondrosarcoma
van Oosterwijk, J. G., Anninga, J., Gelderblom, H. A. J., Cleton-Jansen, A., & Bovée, J. V. M. G. (2013) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.07.012 · Cited by 85
Whelan, J., Seddon, B. M., & Perisoglou, M. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0020-y · Cited by 84
Eselgrim, M., Grunert, H., Kühne, T., Zoubek, A., Kevric, M., Buerger, H., Jürgens, H., Mayer‐Steinacker, R., Gosheger, G., & Bielack, S. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20608 · Cited by 79
Anderson, P. M., Meyers, P. A., Kleinerman, E. S., Venkatakrishnan, K., Hughes, D. P. M., Herzog, C. E., Huh, W. W., Sutphin, R. M., Vyas, Y. M., Shen, V., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24686 · Cited by 77
Self-citationImpact of close surgical margin on local recurrence and survival in osteosarcoma
Li, X., Moretti, V. M., Ashana, A. O., & Lackman, R. D. (2011) · International Orthopaedics · doi:10.1007/s00264-011-1230-x · Cited by 76
Palliative therapy for osteosarcoma
Errani, C., Longhi, A., Rossi, G., Rimondi, E., Biazzo, A., Toscano, A., Alì, N., Ruggieri, P., Alberghini, M., Picci, P., et al. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.172 · Cited by 73
Choy, E., Hornicek, F. J., MacConaill, L. E., Harmon, D. C., Tariq, Z., Garraway, L. A., & Duan, Z. (2011) · Cancer · doi:10.1002/cncr.26617 · Cited by 70
Osteosarcoma in very young children: Experience of the Cooperative Osteosarcoma Study Group
Kager, L., Zoubek, A., Dominkus, M., Lang, S., Bodmer, N., Jundt, G., Klingebiel, T., Jürgens, H., Gadner, H., Bielack, S., et al. (2010) · Cancer · doi:10.1002/cncr.25287 · Cited by 69
Multimodality treatment of osteosarcoma: Radiation in a high‐risk cohort
Mahajan, A., Woo, S. Y., Kornguth, D. G., Hughes, D. P. M., Huh, W. W., Chang, E. L., Herzog, C. E., Pelloski, C. E., & Anderson, P. M. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21451 · Cited by 68
Osteosarcoma Lung Metastases Detection and Principles of Multimodal Therapy
Carrle, D., & Bielack, S. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_8 · Cited by 65
Imran, H., Enders, F., Krailo, M., Sim, F. H., Okuno, S. H., Hawkins, D. S., Neglia, J. P., Randall, R. L., Womer, R. B., Mascarenhas, L., et al. (2009) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.h.00449 · Cited by 61
Osteosarcoma: The Same Old Drugs or More?
Bielack, S., Marina, N. M., Ferrari, S., Helman, L. J., Smeland, S., Whelan, J., & Reaman, G. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1108 · Cited by 60
Bacci, G., Longhi, A., Bertoni, F., Briccoli, A., Versari, M., Pignotti, E., & Picci, P. (2006) · Acta Orthopaedica · doi:10.1080/17453670610013268 · Cited by 59
Smeland, S., Bruland, Ø. S., Hjorth, L., Brosjö, O., Bjerkehagen, B., Österlundh, G., Jakobson, Å. M., Hall, K. S., Monge, O. R., Björk, O., et al. (2011) · Acta Orthopaedica · doi:10.3109/17453674.2011.566141 · Cited by 57
The Scandinavian Sarcoma Group experience
Smeland, S., Wiebe, T., Brosjö, O., Böhling, T., Alvegård, T. A., & Ix, S. (2004) · Cited by 51
Poor Survival for Osteosarcoma of the Pelvis: A Report from the Children’s Oncology Group
Isakoff, M. S., Barkauskas, D. A., Ebb, D. H., Morris, C. D., & Letson, D. G. (2012) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-012-2284-9 · Cited by 48
Clinico-histologic parameters of osteosarcoma patients with late relapse
Hauben, E. I., Bielack, S., Grimer, R. J., Jundt, G., Reichardt, P., Sydes, M. R., Taminiau, A. H. M., & Hogendoorn, P. C. W. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.032 · Cited by 48
Ferrari, S., Palmerini, E., Staals, E. L., Mercuri, M., Bertoni, F., Picci, P., & Bacci, G. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_14 · Cited by 47
Bacci, G., Ferrari, C., Longhi, A., Ferrari, S., Forni, C., Bacchini, P., Palmerini, E., Briccoli, A., Pignotti, E., Balladelli, A., et al. (2006) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000243664.02174.73 · Cited by 38
Sex- and Age-Related Chemotherapy Toxicity in Patients with Non-Metastatic Osteosarcoma
Ferrari, S. M., Palmerini, E., Staals, E. L., Abate, M. E., Longhi, A., Cesari, M., Balladelli, A., Pratelli, L., & Bacci, G. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.2.205 · Cited by 35
European Osteosarcoma Intergroup
van der Eijken, J. W. (1989) · Springer eBooks · doi:10.1007/978-4-431-68072-7_18 · Cited by 32
Complexities in Interpretation of Osteosarcoma Clinical Trial Results
Hunsberger, S., Freidlin, B., & Smith, M. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3484 · Cited by 30
Berger, M., Grignani, G., Giostra, A., Ferrari, S. M., Ferraresi, V., Tamburini, A., Cefalo, G., Carnevale‐Schianca, F., Vassallo, E., Picci, P., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr542 · Cited by 29
Treatment of Osteosarcoma. The Scandinavian Sarcoma Group Experience
Bruland, Ø. S., Bauer, H. C. F., Alvegaard, T. A., et al. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_16 · Cited by 28
Solitary skeletal osteosarcoma recurrence. Findings from the Cooperative Osteosarcoma Study Group
Franke, M., Hardes, J., Helmke, K., Jundt, G., Jürgens, H., Kempf‐Bielack, B., Kevric, M., Tunn, P., Werner, M., & Bielack, S. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22864 · Cited by 25
Muñoz, A., Alfaro, J., Pardo, N., García‐Miguel, P., Quintero, V., Gros, L., Melero, C., Antuña, M. J., Ocete, G., Heras, J. D. L., et al. (2009) · Clinical & Translational Oncology · doi:10.1007/s12094-009-0373-3 · Cited by 17
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Current and future therapeutic approaches for osteosarcoma
Harrison, D. J., Geller, D. S., Gill, J. D., Lewis, V. O., & Gorlick, R. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1413939 · Cited by 689
Update on Survival in Osteosarcoma
Anderson, M. E. (2016) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2015.08.022 · Cited by 560
Grignani, G., Palmerini, E., Ferraresi, V., D'Ambrosio, L., Bertulli, R., Asaftei, S. D., Tamburini, A., Pignochino, Y., Sangiolo, D., Marchesi, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71136-2 · Cited by 340
PI3K/Akt signaling in osteosarcoma
Zhang, J., Yu, X.-H., Yan, Y.-G., Wang, C., & Wang, W.-J. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.12.041 · Cited by 327
Metadata
- Authors
- Luetke, A., Meyers, P. A., Lewis, I., & Juergens, H.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 40
- Issue
- 4
- Pages
- 523-532
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W1986690159
- Cited by
- 1,234
- References
- 95
- FWCI
- 44.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.